Peripheral blood mononuclear cell gene expression in chronic obstructive pulmonary disease

American Journal of Respiratory Cell and Molecular Biology

Volumn 49, Issue 2, 2013, Pages 316-323

  Bahr, Timothy M ^a,d   Hughes, Grant J ^a   Armstrong, Michael ^b   Reisdorph, Rick ^b   Coldren, Christopher D ^c   Edwards, Michael G ^a   Schnell, Christina ^b   Kedl, Ross ^b   LaFlamme, Daniel J ^b   Reisdorph, Nichole ^b   Kechris, Katerina J ^a   Bowler, Russell P ^b  

^a UNIVERSITY OF COLORADO   (United States)

^b DEPARTMENT OF MEDICINE   (United States)

^c VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^d UNIVERSITY OF IOWA   (United States)

Author keywords

Airflow obstruction; Leukocytes; Microarray analysis; Mononuclear; Shronic

Indexed keywords

ACID CERAMIDASE; BIOLOGICAL MARKER; CERAMIDE DERIVATIVE; FORKHEAD TRANSCRIPTION FACTOR; GALABIOSYLCERAMIDE; SPHINGOLIPID; TRANSCRIPTION FACTOR 7; TRANSCRIPTION FACTOR FOXP1; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; EMPHYSEMA; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; IMMUNE SYSTEM; INFLAMMATION; LIPID METABOLISM; MAJOR CLINICAL STUDY; MALE; METABOLOMICS; MICROARRAY ANALYSIS; MOLECULAR PATHOLOGY; MULTIPLEX POLYMERASE CHAIN REACTION; PERIPHERAL BLOOD MONONUCLEAR CELL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SMOKING;

AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; FEMALE; GANGLIOSIDES; GENE EXPRESSION REGULATION; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; METABOLOMICS; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; PULMONARY EMPHYSEMA; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 84883185155     PISSN: 10441549     EISSN: 15354989     Source Type: Journal    
DOI: 10.1165/rcmb.2012-0230OC     Document Type: Article

References (55)

1. Skrepnek GH, Skrepnek SV. Epidemiology, clinical and economic burden, and natural history of chronic obstructive pulmonary disease and asthma. Am J Manag Care 2004;10:S129-S138.
2. Eisner MD, Balmes J, Katz PP, Trupin L, Yelin EH, Blanc PD. Lifetime environmental tobacco smoke exposure and the risk of chronic obstructive pulmonary disease. Environ Health 2005;4:7.
3. Silverman EK, Spira A, Pare PD. Genetics and genomics of chronic obstructive pulmonary disease. Proc Am Thorac Soc 2009;6: 539-542.
4. Silverman EK, Chapman HA, Drazen JM, Weiss ST, Rosner B, Campbell EJ, O'Donnell WJ, Reilly JJ, Ginns L, Mentzer S, et al. Genetic epidemiology of severe, early-onset chronic obstructive pulmonary disease: risk to relatives for airflow obstruction and chronic bronchitis. Am J Respir Crit Care Med 1998;157: 1770-1778.
5. Kim WJ, Hoffman E, Reilly J, Hersh C, Demeo D, Washko G, Silverman EK. Association of COPD candidate genes with computed tomography emphysema and airway phenotypes in severe COPD. Eur Respir J 2011;37: 39-43.
6. Snoeck-Stroband JB, Lapperre TS, Gosman MM, Boezen HM, Timens W, ten Hacken NH, Sont JK, Sterk PJ, Hiemstra PS; Groningen Leiden Universities Corticosteroids in Obstructive Lung Disease (GLUCOLD) Study Group. Chronic bronchitis sub-phenotype within COPD: inflammation in sputum and biopsies.Eur Respir J 2008;31: 70-77.
7. Hurst JR, Vestbo J, Anzueto A, Locantore N, Mullerova H, Tal-Singer R, Miller B, Lomas DA, Agusti A, Macnee W, et al. Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med 2010;363: 1128-1138.
8. Roy K, Smith J, Kolsum U, Borrill Z, Vestbo J, Singh D. COPD phenotype description using principal components analysis. Respir Res 2009;10:41.
9. Bon JM, Leader JK, Weissfeld JL, Coxson HO, Zheng B, Branch RA, Kondragunta V, Lee JS, Zhang Y, Choi AMK, et al. The influence of radiographic phenotype and smoking status on peripheral blood biomarker patterns in chronic obstructive pulmonary disease. PLoS ONE 2009;4:e6865.
10. Agusti AG, Noguera A, Sauleda J, Sala E, Pons J, Busquets X. Systemic effects of chronic obstructive pulmonary disease. Eur Respir J 2003; 21: 347-360.
11. Oudijk EJ, Lammers JW, Koenderman L. Systemic inflammation in chronic obstructive pulmonary disease. Eur Respir J 2003;46:5s-13s.
12. Koutsokera A, Stolz D, Loukides S, Kostikas K. Systemic biomarkers in exacerbations of COPD: the evolving clinical challenge. Chest 2012; 141: 396-405.
13. Foschino Barbaro MP, Carpagnano GE, Spanevello A, Cagnazzo MG, Barnes PJ. Inflammation, oxidative stress and systemic effects in mild chronic obstructive pulmonary disease. Int J Immunopathol Pharmacol 2007;20: 753-763.
14. Bhattacharya S, Srisuma S, Demeo DL, Shapiro SD, Bueno R, Silverman EK, Reilly JJ, Mariani TJ. Molecular biomarkers for quantitative and discrete COPD phenotypes. Am J Respir Cell Mol Biol 2009;40: 359-367.
15. Ning W, Li CJ, Kaminski N, Feghali-Bostwick CA, Alber SM, Di YP, Otterbein SL, Song R, Hayashi S, Zhou Z, et al. Comprehensive gene expression profiles reveal pathways related to the pathogenesis of chronic obstructive pulmonary disease. Proc Natl Acad Sci USA 2004;101: 14895-14900.
16. Pierrou S, Broberg P, O'Donnell RA, Pawlowski K, Virtala R, Lindqvist E, Richter A, Wilson SJ, Angco G,Möller S, et al. Expression of genes involved in oxidative stress responses in airway epithelial cells of smokers with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2007;175: 577-586.
17. Spira A, Beane J, Pinto-Plata V, Kadar A, Liu G, Shah V, Celli B, Brody JS. Gene expression profiling of human lung tissue from smokers with severe emphysema. Am J Respir Cell Mol Biol 2004;31: 601-610.
18. Francis SM, Larsen JE, Pavey SJ, Bowman RV, Hayward NK, Fong KM, Yang IA. Expression profiling identifies genes involved in emphysema severity. Respir Res 2009;10:81.
19. Mohr S, Liew CC. The peripheral-blood transcriptome: new insights into disease and risk assessment. Trends Mol Med 2007;13: 422-432.
20. Bhattacharya S, Tyagi S, Srisuma S, Demeo DL, Shapiro SD, Bueno R, Silverman EK, Reilly JJ, Mariani TJ. Peripheral blood gene expression profiles in COPD subjects. J Clin Bioinform 2011;1:12.
21. Poliska S, Csanky E, Szanto A, Szatmari I, Mesko B, Szeles L, Dezso B, Scholtz B, Podani J, Kilty I, et al. Chronic obstructive pulmonary disease-specific gene expression signatures of alveolar macrophages as well as peripheral blood monocytes overlap and correlate with lung function. Respiration 2011;81: 499-510.
22. Edmiston JS, Archer KJ, Scian MJ, Joyce AR, Zedler BK, Murrelle EL. Gene expression profiling of peripheral blood leukocytes identifies potential novel biomarkers of chronic obstructive pulmonary disease in current and former smokers. Biomarkers 2010;15: 715-730.
23. Regan EA, Hokanson JE, Murphy JR, Make B, Lynch DA, Beaty TH, Curran-Everett D, Silverman EK, Crapo JD. Genetic epidemiology of COPD (COPDGene) study design. COPD 2010;7: 32-43.
24. Fabbri LM, Hurd SS. Global strategy for the diagnosis, management and prevention of COPD: 2003 update. Eur Respir J 2003;22: 1-2.
25. Washko GR, Hunninghake GM, Fernandez IE, Nishino M, Okajima Y, Yamashiro T, Ross JC, Estépar RS, Lynch DA, Brehm JM, et al. Lung volumes and emphysema in smokers with interstitial lung abnormalities. N Engl J Med 2011;364: 897-906.
26. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc B Met 1995;57: 289-300.
27. Stouffer SA, Suchman EA, DeVinney LC, Star SA,Williams RM Jr. The American soldier, volume 1: adjustment during army life. Princeton: Princeton University Press; 1949.
28. Petrache I, Petrusca DN, Bowler RP, Kamocki K. Involvement of ceramide in cell death responses in the pulmonary circulation. Proc Am Thorac Soc 2011;8: 492-496.
29. Wouters EF, Creutzberg EC, Schols AM. Systemic effects in COPD. Chest 2002;121:127S-130S.
30. Aldonyte R, Eriksson S, Piitulainen E,Wallmark A, Janciauskiene S. Analysis of systemic biomarkers in COPD patients. COPD 2004;1: 155-164.
31. Sonna LA, Wenger CB, Flinn S, Sheldon HK, Sawka MN, Lilly CM. Exertional heat injury and gene expression changes: a DNA microarray analysis study. J Appl Physiol 2004;96: 1943-1953.
32. Tang BM, McLean AS, Dawes IW, Huang SJ, Lin RC. Gene-expression profiling of peripheral blood mononuclear cells in sepsis. Crit Care Med 2009;37: 882-888.
33. Iglesias AH, Camelo S, Hwang D, Villanueva R, Stephanopoulos G, Dangond F. Microarray detection of E2F pathway activation and other targets in multiple sclerosis peripheral blood mononuclear cells. J Neuroimmunol 2004;150: 163-177.
34. Hong-Geller E, Pardington PE, Cary RB, Sauer NN, Gupta G. Chemokine regulation in response to beryllium exposure in human peripheral blood mononuclear and dendritic cells. Toxicology 2006; 218: 216-228.
35. Showe MK, Vachani A, Kossenkov AV, Yousef M, Nichols C, Nikonova EV, Chang C, Kucharczuk J, Tran B, Wakeam E, et al. Gene expression profiles in peripheral blood mononuclear cells can distinguish patients with non-small cell lung cancer from patients with nonmalignant lung disease. Cancer Res 2009;69: 9202-9210.
36. Bull TM, Coldren CD, Moore M, Sotto-Santiago SM, Pham DV, Nana- Sinkam SP, Voelkel NF, Geraci MW. Gene microarray analysis of peripheral blood cells in pulmonary arterial hypertension. Am J Respir Crit Care Med 2004;170: 911-919.
37. Subrata LS, Bizzintino J, Mamessier E, Bosco A, McKenna KL, Wikström ME, Goldblatt J, Sly PD, Hales BJ, Thomas WR, et al. Interactions between innate antiviral and atopic immunoinflammatory pathways precipitate and sustain asthma exacerbations in children. J Immunol 2009;183: 2793-2800.
38. Raghavachari N, Xu X, Munson PJ, Gladwin MT. Characterization of whole blood gene expression profiles as a sequel to globin mRNA reduction in patients with sickle cell disease. PLoS ONE 2009;4:e6484.
39. Koch J, Gartner S, Li CM, Quintern LE, Bernardo K, Levran O, Schnabel D, Desnick RJ, Schuchman EH, Sandhoff K. Molecular cloning and characterization of a full-length complementary DNA encoding human acid ceramidase: identification of the first molecular lesion causing Farber disease. J Biol Chem 1996;271: 33110-33115.
40. Su AI, Wiltshire T, Batalov S, Lapp H, Ching KA, Block D, Zhang J, Soden R, Hayakawa M, Kreiman G, et al. A gene atlas of the mouse and human protein-encoding transcriptomes. Proc Natl Acad Sci USA 2004;101: 6062-6067.
41. Petrusca DN, Gu Y, Adamowicz JJ, Rush NI, Hubbard WC, Smith PA, Berdyshev EV, Birokov KG, Lee CH, Tuder RM, et al. Sphingolipidmediated inhibition of apoptotic cell clearance by alveolar macrophages. J Biol Chem 2010;285: 40322-40332.
42. Brown LK, Miller A, Bhuptani A, Sloane MF, Zimmerman MI, Schilero G, Eng CM, Desnick RJ. Pulmonary involvement in Fabry disease. Am J Respir Crit Care Med 1997;155: 1004-1010.
43. Kariman K, Singletary WV Jr, Sieker HO. Pulmonary involvement in Fabry's disease. Am J Med 1978;64: 911-912.
44. Mao C, Obeid LM. Ceramidases: regulators of cellular responses mediated by ceramide, sphingosine, and sphingosine-1-phosphate. Biochim Biophys Acta 2008;1781: 424-434.
45. Shu W, Lu MM, Zhang Y, Tucker PW, Zhou D, Morrisey EE. FOXP2 and FOXP1 cooperatively regulate lung and esophagus development. Development 2007;134: 1991-2000.
46. Chokas AL, Trivedi CM, LuMM, Tucker PW, Li S, Epstein JA, Morrisey EE. FOXP1/2/4-NuRD interactions regulate gene expression and epithelial injury response in the lung via regulation of interleukin-6. J Biol Chem 2010;285: 13304-13313.
47. Shi C, Zhang X, Chen Z, Sulaiman K, FeinbergMW, Ballantyne CM, et al. Integrin engagement regulates monocyte differentiation through the Forkhead transcription factor FOXP1. J Clin Invest 2004;114: 408-418.
48. Moller-Larsen S, NyegaardM,Haagerup A, Vestbo J, Kruse TA, Borglum AD. Association analysis identifies TLR7 and TLR8 as novel risk genes in asthma and related disorders. Thorax 2008;63: 1064-1069.
49. Varkey JB, Varkey B. Viral infections in patients with chronic obstructive pulmonary disease. Curr Opin Pulm Med 2008;14: 89-94.
50. Kaskow BJ, Michael Proffit J, Blangero J, Moses EK, Abraham LJ. Diverse biological activities of the vascular non-inflammatory molecules: the Vanin pantetheinases. Biochem Biophys Res Commun 2012;417: 653-658.
51. Koike S, Takeda Y, Hozumi Y, Okazaki S, Aoyagi M, Sendo F. Immunohistochemical localization in human tissues of GPI-80, a novel glycosylphosphatidyl inositol-anchored protein that may regulate neutrophil extravasation. Cell Tissue Res 2002;307: 91-99.
52. Bryant PA, Smyth GK, Robins-Browne R, Curtis N. Technical variability is greater than biological variability in a microarray experiment but both are outweighed by changes induced by stimulation. PLoS ONE 2011;6:e19556.
53. Charlesworth JC, Curran JE, Johnson MP, Goring HH, Dyer TD, Diego VP, Kent JW Jr, Mahaney MC, Almasy L, MacCluer JW, et al. Transcriptomic epidemiology of smoking: the effect of smoking on gene expression in lymphocytes. BMC Med Genomics 2010;3:29.
54. van Leeuwen DM, van Agen E, Gottschalk RW, Vlietinck R, Gielen M, van Herwijnen MH, et al. Cigarette smoke-induced differential gene expression in blood cells from monozygotic twin pairs. Carcinogenesis 2007;28: 691-697.
55. van Leeuwen DM, Gottschalk RW, van Herwijnen MH, Moonen EJ, Kleinjans JC, van Delft JH. Differential gene expression in human peripheral blood mononuclear cells induced by cigarette smoke and its constituents. Toxicol Sci 2005;86: 200-210.